Phase IV Study to Assess the Safety and Effectiveness of Dienogest (Visanne) Amongst Indian Women With Endometriosis, in Real-world Clinical Practice: the VISAGE Study
Latest Information Update: 17 Jul 2024
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis
- Focus Adverse reactions
- Acronyms VISAGE
- Sponsors Bayer
- 05 Jul 2024 Planned End Date changed from 28 Jun 2024 to 31 Jul 2024.
- 06 Jun 2024 Planned End Date changed from 31 May 2024 to 28 Jun 2024.
- 08 Apr 2024 Planned End Date changed from 5 Apr 2024 to 31 May 2024.